Sodium Valproate: Safety

Department of Health and Social Care written question – answered at on 22 September 2023.

Alert me about debates like this

Photo of Gavin Williamson Gavin Williamson Conservative, South Staffordshire

To ask the Secretary of State for Health and Social Care, whether his Department has plans to raise awareness among (a) healthcare professionals and (b) patients of the safe (i) prescription and (ii) use of sodium valproate.

Photo of Maria Caulfield Maria Caulfield The Parliamentary Under-Secretary for Health and Social Care, Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

Information to support the safe use of medicines such as valproate is provided in the product information which consists of the summary of product characteristics for healthcare professionals and the patient information leaflet that is supplied with each pack of medicines. The Medicines and Healthcare products Regulatory Agency has issued many communications in its Drug Safety Update bulletin informing and raising awareness among healthcare professionals about safety concerns associated with valproate, particularly the risks associated with use of valproate during pregnancy.

Preparations are underway to introduce new measures to ensure all healthcare professionals and patients are aware of the reproductive risks associated with valproate which will be supported by a comprehensive information once the details are finalised.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.